Depletion of serotonin decreases the effects of the kappa-opioid receptor agonist U-69593 on cocaine-stimulated activity

European Journal of Pharmacology

Volumn 586, Issue 1-3, 2008, Pages 123-129

  Zakharova, Elena ^a   Collins, Stephanie L ^a   Åberg, Maria ^a   Kumar, Adarsh ^a   Fernandez, J B ^a   Izenwasser, Sari ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Kappa opioid; Locomotor activity; PCA; Sensitization; Serotonin

Indexed keywords

AMPHETAMINE DERIVATIVE; COCAINE; KAPPA OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; PARACHLOROAMPHETAMINE; SEROTONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; SENSITIZATION; SEROTONINERGIC SYSTEM; STIMULATION;

ANIMALS; AUTORADIOGRAPHY; BENZENEACETAMIDES; BRAIN CHEMISTRY; CITALOPRAM; COCAINE; MALE; MOTOR ACTIVITY; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 43549088290     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.065     Document Type: Article

References (44)

1. Acri J.B., Thompson A.C., and Shippenberg T.S. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Synapse 39 (2001) 343-350
2. Adams D.H., Hanson G.R., and Keefe K.A. Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix. Journal of Neurochemistry 84 (2003) 87-93
3. Battaglia G., Sharkey J., Kuhar M.J., and Souza E.B.d. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Synapse 8 (1991) 249-260
4. Boja J.W., McNeill R.M., Lewin A.H., Abraham P., Carroll F.I., and Kuhar M.J. Selective dopamine transporter inhibition by cocaine analogs. NeuroReport 3 (1992) 984-986
5. Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parham K.A., Abraham P., Lewin A.H., Boja J.W., and Kuhar M.J. Cocaine and 3beta-(4¢-substituted phenyl)tropane-2beta-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. Journal of Medicinal Chemistry 38 (1995) 379-388
6. Chefer V.I., Moron J.A., Hope B., Rea W., and Shippenberg T.S. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience 101 (2000) 619-627
7. Collins S.L., D'Addario C., and Izenwasser S. Effects of kappa opioid receptor agonists in long-term cocaine use and dopamine neurotransmission. European Journal of Pharmacology 426 (2001) 25-34
8. Collins S.L., Gerdes R.M., D'Addario C., and Izenwasser S. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity. Behavioural Pharmacology 12 (2001) 237-245
9. Collins S.L., D'Addario C., Romualdi P., Candeletti S., and Izenwasser S. Regulation of dynorphin gene expression by kappa-opioid agonist treatment. NeuroReport 13 (2002) 107-109
10. Collins S.L., Kunko P.M., Ladenheim B., Cadet J.-L., Carroll F.I., and Izenwasser S. Chronic cocaine increases κ-opioid receptor density: lack of effect by selective dopamine uptake inhibitors. Synapse 45 (2002) 153-158
11. D'Addario C., Di Benedetto M., Candeletti S., and Romualdi P. The kappa-opioid receptor agonist U-69593 prevents cocaine-induced phosphorylation of DARPP-32 at Thr(34) in the rat brain. Brain Research Bulletin 73 (2007) 34-39
12. D'Addario C., Di Benedetto M., Izenwasser S., Candeletti S., and Romualdi P. Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS. Neuroscience 144 (2007) 157-164
13. Daunais J.B., Roberts D.C.S., and McGinty J.F. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. NeuroReport 4 (1993) 543-546
14. Di Benedetto M., D'Addario C., Collins S., Izenwasser S., Candeletti S., and Romualdi P. Role of serotonin on cocaine-mediated effects on prodynorphin gene expression in the rat brain. Journal of Molecular Neuroscience 22 (2004) 213-222
15. Fuller R.W. Effects of p-chloroamphetamine on brain serotonin neurons. Neurochemical Research 17 (1992) 449-456
16. Hasebe K., Kawai K., Suzuki T., Kawamura K., Tanaka T., Narita M., Nagase H., and Suzuki T. Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence. Ann N Y Acad Sci. 1025 (2004) 404-413
17. Heidbreder C.A., and Shippenberg T.S. U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. Neuroreport 5 (1994) 1797-1800
18. Heidbreder C.A., Goldberg S.R., and Shippenberg T.S. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Research 616 (1993) 335-338
19. Hurd Y.L., and Herkenham M. Neuropeptide compartmentalization within the human neostriatum: in situ hybridization and in vitro autoradiography characterization. Neuroscience 64 (1995) 571-586
20. Kennett G.A., Dickinson S.L., and Curzon G. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Research 330 (1985) 253-263
21. Margolis E.B., Lock H., Chefer V.I., Shippenberg T.S., Hjelmstad G.O., and Fields H.L. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 2938-2942
22. Mathieu-Kia A., and Besson M. Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Molecular Brain Research 54 (1998) 141-151
23. Mello N.K., and Negus S.S. Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 286 (1998) 8812-8824
24. Nabeshima T., Katho A., Wada M., and Kameyama T. Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations. Life Sciences 51 (1992) 211-217
25. Nemmani K.V.S., and Mogil J.S. Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia. Neuropharmacology 44 (2003) 304-310
26. Park H., Lee H., Kim Y., Park J., Zvartau E., and Lee H. A highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability. Bioorganic & Medicinal Chemistry Letters 16 (2006) 3609-3613
27. Pfeiffer A., Brantl V., Herz A., and Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 233 (1986) 774-776
28. Pompeiano M., Palacios J.M., and Mengood G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Research - Molecular Brain Research 23 (1994) 163-178
29. Powell K.R., Picker M.J., and Dykstra L.A. Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats. Behavioural Pharmacology 5 (1994) 255-264
30. Romualdi P., Donatini A., Izenwasser S., Cox B.M., and Ferri S. Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate putamen. Molecular Brain Research 40 (1996) 153-156
31. Romualdi P., D'Addario C., Ferri S., Cox B.M., and Izenwasser S. Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine. European Journal of Pharmacology 413 (2001) 207-212
32. Samuel D., Goff L.K.-L., Kumar U., Errami M., Scarfone E., and Nieoullon A. Changes in striatal cholinergic, gabaergic, dopaminergic and serotoninergic biochemical markers after kainic acid-induced thalamic lesions in the rat. Journal of Neural Transmission 2 (1990) 193-203
33. Sanders-Bush E., Bushing J.A., and Sulser F. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. Journal of Pharmacology and Experimental Therapeutics 192 (1975) 33-41
34. Schenk S., Partridge B., and Shippenberg T. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology 144 (1999) 339-346
35. Schenk S., Partridge B., and Shippenberg T. Reinstatement of extinguished drug-taking behavior in rats: effects of the kappa-opioid receptor agonist, U69593. Psychopharmacology 151 (2000) 85-90
36. Shippenberg T.S., LeFevour A., and Heidbreder C. κ-opioid agonists prevent sensitization to the conditioned rewarding effects of cocaine. Journal of Pharmacology and Experimental Therapeutics 276 (1996) 545-554
37. Spangler R., Ho A., Zhou Y., Maggos C.E., Yuferov V., and Kreek M.J. Regulation of kappa opioid receptor mRNA in the rat brain by "binge' pattern cocaine administration and correlation with preprodynorphin mRNA. Brain Research-Molecular Brain Research 38 (1996) 71-76
38. Sprague J.E., Johnson M.P., Schmidt C.J., and Nichols D.E. Studies on the mechanism of p-chloroamphetamine neurotoxicity. Biochemical Pharmacology 52 (1996) 1271-1277
39. Svenningsson P., Nishi A., Fisone G., Girault J.A., Nairn A.C., and Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology 44 (2004) 269-296
40. Thompson A.C., Zapata A., Justice Jr. J.B., Vaughan R.A., Sharpe L.G., and Shippenberg T.S. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. Journal of Neuroscience 20 (2000) 9333-9340
41. Turchan J., Przewlocka B., Lason W., and Przewlocki R. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience 85 (1998) 1051-1059
42. Unterwald E.M., Rubenfeld J.M., and Kreek M.J. Repeated cocaine administration upregulates κ and μ, but not δ, opioid receptors. NeuroReport 5 (1994) 1613-1616
43. Von Voigtlander P.F., Lewis R.A., and Neff G.L. Kappa opioid analgesia is dependent on serotonergic mechanisms. Journal of Pharmacology and Experimental Therapeutics 231 (1984) 270-274
44. Vorhees C.V., Schaefer G.J., and Barrett R.J. p-Chloroamphetamine: behavioral effects of reduced cerebral serotonin in rats. Pharmacology Biochemistry and Behavior 3 (1975) 279-284